Atlas Trials

A Prospective Pharmacodynamic Study of Rivaroxaban

Clinical trial NCT01743898 · COMPLETED

Trial details

NCT number
NCT01743898
Sponsor
University of North Carolina, Chapel Hill
Status
COMPLETED
Study type
OBSERVATIONAL
Blood Clot
Start date
2012-10-01
Primary completion
2013-03-01
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.